Market by Gender, Indications, Treatment Type, Sales Channel, and Country | Forecast 2021-2028
In
its report on the hair loss treatment market in the Middle East and Africa,
Triton Market Research has concluded that this industry will progress with a
CAGR of 4.32% in the forecast years between 2021 and 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries analyzed in this market include:
•          South Africa
•          The United Arab Emirates
•          Turkey
•          Saudi Arabia
•          Rest of MEA countries
The
prevalence of alopecia conditions is rising in the Middle Eastern countries,
which can be attributed to the extreme weather conditions and pollution. Also, stress,
dehydration, unhealthy diets, and thyroid disease are other factors
contributing to this hair loss problem. Hard water is available here, which
damages the hair follicles further and increases the chances of alopecia. Owing
to these factors, hair loss treatment techniques, such as hair restoration
therapies and grafting, are garnering huge demand here.
The
UAE is immensely popular globally for its state-of-the-art healthcare
infrastructure and booming medical tourism industry. A large number of patients
fly down every year to places like Dubai, for hair transplantation. These
factors are boosting the growth of the hair loss treatment market in the UAE.
Furthermore,
the country is seeing a rise in the cases of autoimmune diseases, especially
cancer. However, given the young demographic profile of the country, survival
rates from cancer are also expected to increase. This will increase the
incidence of hair loss in the patients in the future, post their recovery. The
growing cancer prevalence is expected to further strengthen the growth of the
UAE’s hair loss treatment market in the coming years.
Teva
Pharmaceutical Industries Ltd is a generic pharmaceutical company engaged in the
development, manufacturing, and marketing of generic and proprietary branded
pharmaceuticals and APIs. It offers a broad range of generic medicines in
different forms, including tablets, capsules, inhalants, injectables, liquids,
creams, and ointments. Other than these, the company also provides OTC
products. For its hair loss treatment products range, it offers finasteride
tablets and a minoxidil topical solution. Founded in 1901, Teva Pharmaceutical
is headquartered in Petach Tikva, Israel.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. EFFORTS
TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD
2.2.2. DEVELOPMENT
OF ROBOT HAIR RESTORATION SYSTEM
2.2.3. INTENSIVE
RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. CONTRACTS
& AGREEMENTS
2.6.4. INVESTMENT
& EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN CASES OF AUTOIMMUNE DISEASE
2.7.2. HIGH
CONSUMPTION OF ALCOHOL AND TOBACCO
2.7.3. UNHEALTHY
DIETARY HABITS
2.7.4. STRESS
AND CHANGING LIFESTYLES
2.8. MARKET
CHALLENGES
2.8.1. RISK
OF INFECTION OR SIDE EFFECTS
2.8.2. HIGH
COST OF TREATMENT
2.9. MARKET
OPPORTUNITIES
2.9.1. R&D
IN HAIR CLONING TECHNOLOGY
2.9.2. DEVELOPMENT
OF BARICITINIB
3. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER
3.1. FEMALE
3.2. MALE
4. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS
4.1. ANDROGENIC
ALOPECIA
4.2. ALOPECIA
AREATA
4.3. ALOPECIA
TOTALIS
4.4. OTHER
INDICATIONS
5. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE
5.1. TOPICAL
HAIR LOSS TREATMENT,
5.1.1. MINOXIDIL
5.1.2. SHAMPOOS
5.2. ORAL
HAIR LOSS TREATMENT
5.2.1. FINASTERIDE
5.2.2. OTHER
ORAL HAIR LOSS TREATMENT
5.3. OTHER
TREATMENT TYPES
6. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL
6.1. DRUG
STORES & RETAIL PHARMACIES
6.2. HOSPITAL
PHARMACIES
6.3. ONLINE
PHARMACIES
7. MIDDLE
EAST AND AFRICA HAIR LOSS TREATMENT MARKET – REGIONAL OUTLOOK
7.1. UNITED
ARAB EMIRATES
7.2. SAUDI
ARABIA
7.3. TURKEY
7.4. SOUTH
AFRICA
7.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. TEVA
PHARMACEUTICALS
8.2. MERCK
& CO
8.3. CIPLA
LIMITED
8.4. JOHNSON
& JOHNSON
8.5. SUN
PHARMACEUTICAL INDUSTRIES LTD
8.6. CONCERT
PHARMACEUTICALS INC
8.7. SHISEIDO
COMPANY LIMITED
8.8. TAISHO
PHARMACEUTICAL CO LTD
8.9. DR REDDYS
LABORATORIES
8.10. THE
HIMALAYA DRUG COMPANY
8.11. TRANSITIONS
HAIR PVT LTD
8.12. LEXINGTON
INTERNATIONAL LLC
8.13. ACLARIS
THERAPEUTICS
8.14. CELLMID
8.15. DAIICHI
SANKYO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: LIST OF INVESTMENT
& EXPANSIONS
TABLE 7: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $
MILLION)
TABLE 11: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: PREVALENCE OF
DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019
FIGURE 3: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 4: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)
FIGURE 7: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)
FIGURE 12: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 &
2028 (IN %)
FIGURE 13: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028
(IN %)
FIGURE 17: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028
(IN $ MILLION)
FIGURE 20: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY OTHERÂ TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)
FIGURE 22: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES,
2021-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 24: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 25: MIDDLE EAST AND
AFRICA HAIR LOSS TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: UNITED ARAB
EMIRATES HAIR LOSS TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: SAUDI ARABIA HAIR
LOSS TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: TURKEY HAIR LOSS
TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: SOUTH AFRICA HAIR
LOSS TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: REST OF MIDDLE EAST
& AFRICA HAIR LOSS TREATMENT MARKET, 2021-2028 (IN $ MILLION)